Liposomal amphotericin B as a treatment for human leishmaniasis.
Balasegaram, Manica
Liposomal amphotericin B as a treatment for human leishmaniasis. [electronic resource] - Expert opinion on emerging drugs Dec 2012 - 493-510 p. digital
Publication Type: Journal Article; Review
1744-7623
10.1517/14728214.2012.748036 doi
Amphotericin B--administration & dosage
Antiprotozoal Agents--administration & dosage
Dose-Response Relationship, Drug
Drug Design
Drugs, Generic--therapeutic use
Health Services Accessibility
Humans
Leishmaniasis--drug therapy
Leishmaniasis, Visceral--drug therapy
Therapeutic Equivalency
Liposomal amphotericin B as a treatment for human leishmaniasis. [electronic resource] - Expert opinion on emerging drugs Dec 2012 - 493-510 p. digital
Publication Type: Journal Article; Review
1744-7623
10.1517/14728214.2012.748036 doi
Amphotericin B--administration & dosage
Antiprotozoal Agents--administration & dosage
Dose-Response Relationship, Drug
Drug Design
Drugs, Generic--therapeutic use
Health Services Accessibility
Humans
Leishmaniasis--drug therapy
Leishmaniasis, Visceral--drug therapy
Therapeutic Equivalency